Advertisement
Logo
Search for

Volume 7, Issue 2, Pages 61-75 (June 2010)


View previous. 2 of 13 View next.

Oncologic photodynamic therapy photosensitizers: A clinical review

Ron R. Allison, MDa, Claudio H. Sibata, PhDabCorresponding Author Informationemail address

published online 23 April 2010.

Summary 

A myriad of naturally occurring and synthetic structures are capable of transferring the energy of light. Few, however, allow for this energy transfer to enable a type II photochemical reaction which, as currently practiced, is a fundamental component of photodynamic therapy. Even fewer of these agents, aptly termed photosensitizers, have found success in the treatment of patients. This review will focus on the oncologic photosensitizers that have come to clinical trial with outcomes published in peer reviewed journals. Based on a clinical orientation the qualities of successful photosensitizers will be examined, how current drugs fare and potential future options explored.

a 21st Century Oncology, Greenville, NC, 27834-3764, USA

b The Brody School of Medicine, Department of Radiation Medicine, East Carolina University, Leo W. Jenkins Cancer Center, Greenville, NC, 27858-4354, USA

Corresponding Author InformationCorresponding author. Tel.: +1 252 744 2900; fax: +1 252 744 3780.

PII: S1572-1000(10)00027-X

doi:10.1016/j.pdpdt.2010.02.001


View previous. 2 of 13 View next.

Advertisement